Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-06
2000-01-18
LeGuyader, John L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 435 9131, 435 9133, 4352523, 4353201, 435325, 435375, 435410, 536 231, 536 232, 536 245, 800205, C12Q 168, C07H 2104, A61K 4800
Patent
active
060157941
ABSTRACT:
The design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a Group I intron are described. Using this design, it is possible to construct ribozymes capable of efficiently splicing a new 3' exon sequence into any chosen target RNA sequence in a highly precise manner. Inactive pro-ribozyme forms are also described.
REFERENCES:
patent: 5037746 (1991-08-01), Cech et al.
San, H. et al., Safety and Short Term Toxicity of a Novel and Cationic Formulation for Human Gene Therapy, Human Gene Therapy, 781-788, Dec. 1993.
Christoffersen, R. et al., Ribozymes as Human Therapeutic Agents, Journal of Medicinal Chemistry, 2023-2037, Nov. 1994.
Stull, R. et al., Antigene, Ribozyme, and Aptomer Nucleic Acid Drugs: Progress and Prospects, Pharmaceuticals Research, 1995.
Agabian, N., "Trans Splicing of Nuclear Pre-mRNAS," Cell 61(7):1157-1160 (Jun. 1990).
Barinaga, M., "Ribozymes: Killing the Messenger," Science 262:1512-1514 (1993).
Been, M.D., et al., "One binding site determines sequence specificity of Tetrahymena pre-mRNA self splicing, trans-splicing, and RNA enzyme activity," Cell 47(2):207-216 (1986).
Been, M.D., et al., "Selection of Circularization Sites in a Group I IVS RNA Requires Multiple Alignments of an Internal Template-Like Sequence," Cell 50:951-961 (1987).
Brand, A., et al., "A General Method for Directed Gene Expression in Drosophila," Presented at The Genome Conference, 13th Annual Conference on the Organisation and Expression of the Genome, Victoria, Australia, Feb. 18-22, 1991, SYM-15-2.
Cech, T.R., "Self-Splicing of Group I Introns," Ann. Rev. Biochem. 59: 543-568 (Jul. 1990).
Cech, T.R., "Conserved sequences and structures of group I introns: building an active site for RNA catalysis--a review," Gene 73:259-271 (1988).
Chuat, J.C., et al., "Can Ribozymes Be Used to Regulate Procaryote Gene Expression?," Biochem. Biophys. Res. Commun. 162(3):1025-1029 (1989).
Cotten, M., et al., "Ribozyme Mediated Destruction of RNA in vivo," EMBO J. 8(12):3861-3866 (1989).
Cotten, M., "The in vivo application of ribozymes," Trends Biotech. 8(7):174-178 (Jul. 1990).
Doudna, J.A., et al., "RNA structure, not sequence, determines the 5' splice-site specificity of a group I intron," Proc. Natl. Acad. Sci. 86:7402-7406 (1989).
Evans, G.A., "Dissecting mouse development with toxigenics," Genes and Develop. 3:259-263 (1982).
Flanegan, J.B., et al., "Tetrahymena Ribozyme Catalyzes Trans-Splicing of Model Oligoribonucleotide Substrates," J. Cell Biochem. Supp. 12D:28 N202 (1988), Presented at the Symposium of the Molecular Biology of RNA Held at the 17th Annual UCLA Symposia on Molecular and Cellular Biology, Keystone, CO (Apr. 1988).
Garriga, G., et al., "Mechanism of recognition of the 5' splice site in self-splicing group I introns," Nature 322:86-89 (1986).
Haseloff, J., et al., "Simple RNA enzymes with new and highly specific endoribonuclease activities," Nature 334:585-591 (1988).
Haseloff, J., et al.,"Design of Ribozymes for Trans-Splicing," Presented at The Genome Conference, 13th Annual Conference on the Organisation and Expression of the Genome, Victoria, Australia, Feb. 18-22, 1991, SYM-8-1.
Heus, H.A., et al., "Sequence-dependent structural variations of hammerhead RNA enzymes," Nucl. Acids Res. 18(5):1103-1108 (Mar. 1990).
Hirsh, D., et al., "Trans-Splicing and SL RNAs in C. elegans," Mol. Biol. Rep. 14(2/3):115 (Mar. 1990).
Hutchins, C.J., et al., "Self-cleavage of plus and minus RNA transcripts of avocado sunblotch viroid," Nucl. Acids. Res. 14(9):3627-3640 (1986).
Joyce, G.F., "Amplification, mutation and selection of catalytic RNA," Gene 82:83-87 (1989).
Kan, N.C., et al., "The intervening sequence of the ribosomal RNA gene is highly conserved between Two Tetrahymena species," Nucl. Acids. Res. 10(9):2809-2822 (1982).
Keese, P., et al., "The Structure of Viroids and Virusoids," in: Viroids and Viroid-like Pathogens, J.S. Semancik, ed., Boca Raton, FL: CRC Press, pp. 1-47 (1987).
Koizumi, M., et al., "Construction of a series of several self-cleaving RNA duplexes using synthetic 21-mers," FEBS Letts. 228(2):228-230 (1988).
Koizumi, M., et al., "Cleavage of specific sites of RNA by designed ribozymes," FEBS Letts. 239(2):285-288 (1988).
Mariani, C., et al., "Induction of male sterility in plants by a chimaeric ribonuclease gene," Nature 347 (6295):737-741 (Oct. 1990).
Maxwell, I.H., et al., "Regulated Expression of a Diphtheria Toxin A-Chain Gene Transfected into Human Cells: Possible Strategy for Inducing Cancer Cell Suicide," Cancer Research 46:4660-4664 (1986).
Michel, F., et al., "The guanosine binding site of the Tetrahymena ribozyme," Nature 342:391-395 (1989).
Rezaian, M.A., et al., "Nucleotide sequence of cucumber mosaic virus RNA 1--Presence of a sequence complementary to part of the viral satellite RNA and homologies with other viral RNAs," Eur. J. Biochem. 150:331-339 (1985).
Riedel, C.J., et al., "Diphtheria toxin mutant selectively kills cerebellar purkinje neurons," Proc. Natl. Acad. Sci. USA 87:5051-5055 (Jul. 1990).
Salvo, J.L.G., et al., "Deletion-tolerance and Trans-splicing of the Bacteriophage T4 td Intron," J. Mol. Biol. 211(3):537-549 (Feb. 1990).
Sarver, N., et al., "Ribozymes as Potential Anti-HIV-1 Therapeutic Agents," Science 247(4947):1222-1225 (Mar. 1990).
Suh, E.R., et al., "Base Pairing between the 3' Exon and an Internal Guide Sequence Increases 3' Splice Site Specificity in the Tetrahymena Self-Splicing rRNA Intron," Mol. Cell. Biol. 10(6):2960-2965 (Jun. 1990).
Sullenger, B.A., et al., "Ribozyme-mediated repair of defective mRNA by targeted trans-splicing," Nature 371:619-622 (1994).
Szostak, J.W., "Enzymatic activity of the conserved core of a group I self-splicing intron," Nature 322:83-86 (1986).
Taira, K., et al., "Construction of a novel artificial-ribozyme-releasing plasmid," Protein Engineering 3(8):733-737 (Aug. 1990).
Waring, R.B., et al., "The Tetrahymena rRNA Intron Self-Splices in E. coli: In Vivo Evidence for the Importance of Key Base-Paired Regions of RNA for RNA Enzyme Function," Cell 40:371-380 (1985).
Winter, A.J., et al., "The mechanism of Group I self-splicing: an internal guide sequence can be provided in Trans," EMBO J. 9(6):1923-1928 (Jun. 1990).
Yagi, T., et al., "Homologous Recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection," Proc. Natl. Acad. Sci. USA 87:9918-9922 (Dec. 1990).
Zaug, A.J., et al., "Intervening Sequence RNA of Tetrahymena Is an Enzyme," Science 231:470-475 (1986).
Goodman Howard M.
Haseloff James
LeGuyader John L.
The General Hospital Corporation
LandOfFree
Trans-splicing ribozymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trans-splicing ribozymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-splicing ribozymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-563472